Comprehensive medication guide to Ergomar including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$80 copay depending on tier and plan; brand-name only, typically placed on higher tiers. Prior authorization or step therapy (triptan failure documentation) may be required. Medicare Part D and commercial plan coverage vary widely.
Estimated Cash Pricing
$322–$2,092 retail for a 20-tablet supply; as low as $845 with a GoodRx coupon at participating pharmacies. Eligible commercially insured patients can pay as little as $0 with the Ergomar Savings Program.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Ergomar is the brand name for ergotamine tartrate 2 mg sublingual tablets, manufactured by Pangea Pharmaceuticals. It is the only sublingual ergotamine product currently available in the United States. Unlike older ergotamine-caffeine combination tablets, Ergomar is caffeine-free and aspartame-free.
Ergomar belongs to a class of drugs called ergot alkaloids—naturally occurring compounds derived from the ergot fungus. It is FDA-approved as an abortive treatment for migraine headaches (with or without aura), migraine variants, and cluster headaches (histaminic cephalalgia).
The tablet is placed under the tongue and allowed to dissolve, entering the bloodstream directly from the sublingual mucosa. This bypasses gastric absorption and first-pass hepatic metabolism, providing faster onset and more reliable delivery—particularly valuable for patients with migraine-associated nausea.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Ergomar works through two complementary mechanisms. First, it acts as an alpha-adrenergic blocking agent that directly constricts vascular smooth muscle, causing the dilated cranial blood vessels responsible for migraine pain to narrow back toward their normal diameter. Vasoconstriction can begin in as little as 15 minutes after a sublingual dose.
Second, ergotamine acts as a partial agonist and antagonist at serotonin (5-HT) receptors, reducing the pain signaling cascade that amplifies migraine pain. This dual mechanism—targeting both the vascular dilation and the neurochemical pain signaling—makes it effective for attacks that are already underway, not just those caught in the earliest stages.
A key clinical advantage of Ergomar over triptans is its longer duration of action. Clinical trial data consistently shows lower headache recurrence rates with ergotamine versus triptans in the 24-hour period following treatment—making it particularly valuable for patients with high-recurrence migraines, menstrual migraines, or multi-day attacks.
2 mg — sublingual tablet
Place under tongue at first sign of attack; may repeat after 30 min; max 2 tablets per attack, 5 tablets per week
As of 2026, Ergomar is not listed on the FDA's Drug Shortage Database—there is no systemic national shortage. However, patients consistently report difficulty finding it at local retail pharmacies. Ergomar receives a findability score of 55 out of 100, reflecting intermittent availability challenges at retail pharmacies rather than a critical supply crisis.
The challenge is structural: Ergomar is a brand-name-only, low-volume specialty medication with a retail cash price exceeding $1,600 per 20-tablet supply. Most retail pharmacies don't stock it routinely because they don't fill enough prescriptions to justify carrying inventory. Specialty pharmacies, high-volume chain locations, and mail-order pharmacies are more reliable sources.
Rather than calling pharmacies individually, patients can use medfinder to have pharmacies near them checked for Ergomar availability. medfinder calls pharmacies on your behalf and texts you the results, saving hours of hold time.
Ergomar is not a DEA-controlled substance, so it does not require special DEA registration or prescribing authority beyond a standard DEA number (required for all prescription drugs). Any licensed prescriber with prescribing authority in their state can write for Ergomar, including:
Neurologists (especially headache medicine subspecialists — most experienced with ergotamine)
Headache specialists (board-certified in headache medicine)
Primary care physicians (PCPs) — family medicine, internal medicine
Nurse practitioners (NPs) — scope varies by state
Physician assistants (PAs) — scope varies by state
Telehealth prescribing is available for Ergomar in most states, as it is not subject to the Ryan Haight Act restrictions that apply to controlled substances. Telehealth platforms specializing in headache medicine (such as Cove or Nurx) and general telehealth services (Teladoc, MDLive) may prescribe Ergomar after completing a clinical evaluation and medication review.
No. Ergomar (ergotamine tartrate) is not a DEA-scheduled controlled substance. It is a prescription-only medication under federal law, meaning it requires a valid prescription from a licensed prescriber to dispense. However, it does not fall under Schedule II–V of the Controlled Substances Act.
As a non-controlled prescription drug, Ergomar can be prescribed via telehealth without the additional DEA registration and prescribing restrictions that apply to controlled substances. Prescriptions can also be called in or faxed rather than requiring a written paper prescription in most states. Refills are allowed per prescriber discretion, without the quantity limits that apply to Schedule II substances.
Note: Despite not being a controlled substance, cases of psychological dependence and drug abuse have been reported with ergotamine tartrate. Patients should take Ergomar only as prescribed and not exceed the dosing limits (5 tablets per week maximum).
The following are commonly reported side effects that often improve over time:
Nausea and vomiting (most common)
Dizziness and weakness
Numbness or tingling in fingers and toes
Transient heart rate changes (bradycardia or tachycardia)
Temporary blood pressure increase
Peripheral ischemia (ergotism): Cold, pale, or blue fingers/toes; burning pain in extremities; absent pulses — can lead to gangrene
Heart attack: Chest pain, shortness of breath, arm/jaw pain — call 911
Stroke: Sudden facial drooping, weakness, speech difficulty, vision loss — call 911
Severe allergic reaction: Facial swelling, throat tightening, hives — call 911
Know what you need? Skip the search.
Sumatriptan (Imitrex)
Most widely available triptan; generic available for $15–$30; multiple forms (pill, nasal spray, injection); faster 2-hour relief but higher recurrence than ergotamine
Rizatriptan (Maxalt)
Fast-acting triptan with orally disintegrating tablet option (MLT); generic available; good for fast-onset migraines
Dihydroergotamine (Migranal, Trudhesa)
Ergot alkaloid closely related to ergotamine; available as nasal spray; long duration of action; similar contraindications to Ergomar
Ubrogepant (Ubrelvy)
CGRP antagonist; no vasoconstrictive effects; option for patients with cardiovascular contraindications to ergotamine and triptans
Rimegepant (Nurtec ODT)
CGRP antagonist with both acute and preventive migraine indications; orally disintegrating tablet; may reduce overall Ergomar demand
Prefer Ergomar? We can find it.
Clarithromycin (Biaxin)
majorCYP3A4 inhibitor — contraindicated; raises ergotamine levels causing life-threatening peripheral ischemia
Erythromycin
majorCYP3A4 inhibitor — contraindicated; same mechanism as clarithromycin
Ritonavir (Norvir) / Cobicistat regimens
majorPotent CYP3A4 inhibitors — contraindicated; severe ergotism and ischemia, including fatal cases reported
Ketoconazole / Itraconazole
majorAzole antifungals; CYP3A4 inhibitors — contraindicated; increased ergotamine levels and ergotism risk
All triptans (sumatriptan, rizatriptan, etc.)
majorAdditive vasospasm — do not use within 24 hours (72 hours for eletriptan)
Propranolol (Inderal) / Beta-blockers
moderatePotentiates ergotamine's vasoconstrictive effects; monitor for ischemia
Pseudoephedrine / Sympathomimetics
moderateAdditive vasopressor effects; avoid concurrent use with decongestants
Nitroglycerin (all forms)
majorErgotamine antagonizes nitrate vasodilatory effects; contraindicated
Ergomar is a clinically valuable, pharmacologically distinct migraine abortive with a role that generic triptans cannot fully replicate. Its sublingual delivery, caffeine-free formulation, and long duration of action—with lower headache recurrence rates than triptans—make it the preferred choice for specific patient populations, particularly those with multi-day attacks, high recurrence, or significant nausea.
The main challenges in 2026 are not clinical—they are logistical and financial. Ergomar is not in an FDA shortage, but its limited retail pharmacy presence and high cash price create real barriers to access. The Ergomar Savings Program can make it nearly cost-free for eligible commercially insured patients. For finding it in stock, specialty and mail-order pharmacies are more reliable than local retail.
If you need help locating Ergomar at a pharmacy near you, medfinder calls pharmacies in your area to check which ones can fill your prescription and texts you the results—so you can spend your energy managing your health, not chasing down your medication.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini